These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 34751215)
1. Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia. Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS Front Mol Neurosci; 2021; 14():711396. PubMed ID: 34751215 [TBL] [Abstract][Full Text] [Related]
2. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson's Disease Dementia. Scholefield M; Church SJ; Xu J; Patassini S; Hooper NM; Unwin RD; Cooper GJS Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564384 [TBL] [Abstract][Full Text] [Related]
3. Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia. Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS Front Aging Neurosci; 2021; 13():641222. PubMed ID: 33746735 [TBL] [Abstract][Full Text] [Related]
4. Human dementia with Lewy bodies brain shows widespread urea elevations. Scholefield M; Church SJ; Philbert S; Xu J; Patassini S; Cooper GJS Parkinsonism Relat Disord; 2024 Jul; 124():107017. PubMed ID: 38788611 [TBL] [Abstract][Full Text] [Related]
5. Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain. Scholefield M; Church SJ; Xu J; Patassini S; Cooper GJS J Parkinsons Dis; 2024; 14(5):965-976. PubMed ID: 38820022 [TBL] [Abstract][Full Text] [Related]
6. Metallomic analysis of brain tissues distinguishes between cases of dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease dementia. Scholefield M; Church SJ; Xu J; Cooper GJS Front Neurosci; 2024; 18():1412356. PubMed ID: 38988772 [TBL] [Abstract][Full Text] [Related]
7. Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson's disease dementia brain. Scholefield M; Church SJ; Taylor G; Knight D; Unwin RD; Cooper GJS NPJ Parkinsons Dis; 2023 Apr; 9(1):66. PubMed ID: 37081022 [TBL] [Abstract][Full Text] [Related]
8. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder. Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286 [TBL] [Abstract][Full Text] [Related]
9. Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease. Patassini S; Begley P; Reid SJ; Xu J; Church SJ; Curtis M; Dragunow M; Waldvogel HJ; Unwin RD; Snell RG; Faull RL; Cooper GJ Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):161-6. PubMed ID: 26522227 [TBL] [Abstract][Full Text] [Related]
10. Extensive multiregional urea elevations in a case-control study of vascular dementia point toward a novel shared mechanism of disease amongst the age-related dementias. Philbert SA; Xu J; Scholefield M; Patassini S; Church SJ; Unwin RD; Roncaroli F; Cooper GJS Front Mol Neurosci; 2023; 16():1215637. PubMed ID: 37520429 [TBL] [Abstract][Full Text] [Related]
11. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects. Davis MY; Keene CD; Jayadev S; Bird T J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863 [TBL] [Abstract][Full Text] [Related]
12. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. Xu J; Church SJ; Patassini S; Begley P; Waldvogel HJ; Curtis MA; Faull RLM; Unwin RD; Cooper GJS Metallomics; 2017 Aug; 9(8):1106-1119. PubMed ID: 28654115 [TBL] [Abstract][Full Text] [Related]
13. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. Jellinger KA J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591 [TBL] [Abstract][Full Text] [Related]
14. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531 [TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation and protein pathology in Parkinson's disease dementia. Kouli A; Camacho M; Allinson K; Williams-Gray CH Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323 [TBL] [Abstract][Full Text] [Related]
17. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292 [TBL] [Abstract][Full Text] [Related]
18. Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target. Scholefield M; Patassini S; Xu J; Cooper GJS EBioMedicine; 2023 Nov; 97():104824. PubMed ID: 37806287 [TBL] [Abstract][Full Text] [Related]
19. A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging. Moon WJ; Park JY; Yun WS; Jeon JY; Moon YS; Kim H; Kwak KC; Lee JM; Han SH Korean J Radiol; 2016; 17(5):633-40. PubMed ID: 27587951 [TBL] [Abstract][Full Text] [Related]
20. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Bibl M; Mollenhauer B; Esselmann H; Lewczuk P; Klafki HW; Sparbier K; Smirnov A; Cepek L; Trenkwalder C; Rüther E; Kornhuber J; Otto M; Wiltfang J Brain; 2006 May; 129(Pt 5):1177-87. PubMed ID: 16600985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]